Switch theme
Sign up to access all valuation multiples
Yunnan Botanee Bio-Technology Group Co Ltd is a health industry group integrating research and development, production, and marketing, and is positioned as a skin health Internet. Betteni is committed to creating a skin health ecology in China and promoting the development of China's skincare industry.
2010
n/a
LTM Revenue $828M
LTM EBITDA $125M
$2.2B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Botanee Group has a last 12-month revenue (LTM) of $828M and a last 12-month EBITDA of $125M.
In the most recent fiscal year, Botanee Group achieved revenue of $796M and an EBITDA of $113M.
Botanee Group expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Botanee Group valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $828M | XXX | $796M | XXX | XXX | XXX |
| Gross Profit | $613M | XXX | $587M | XXX | XXX | XXX |
| Gross Margin | 74% | XXX | 74% | XXX | XXX | XXX |
| EBITDA | $125M | XXX | $113M | XXX | XXX | XXX |
| EBITDA Margin | 15% | XXX | 14% | XXX | XXX | XXX |
| EBIT | $96.8M | XXX | $80.0M | XXX | XXX | XXX |
| EBIT Margin | 12% | XXX | 10% | XXX | XXX | XXX |
| Net Profit | $81.0M | XXX | $69.8M | XXX | XXX | XXX |
| Net Margin | 10% | XXX | 9% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Botanee Group's stock price is CNY 44 (or $6).
Botanee Group has current market cap of CNY 18.7B (or $2.6B), and EV of CNY 15.8B (or $2.2B).
See Botanee Group trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $2.2B | $2.6B | XXX | XXX | XXX | XXX | $0.19 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Botanee Group has market cap of $2.6B and EV of $2.2B.
Botanee Group's trades at 2.8x EV/Revenue multiple, and 19.4x EV/EBITDA.
Equity research analysts estimate Botanee Group's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Botanee Group has a P/E ratio of 32.1x.
See valuation multiples for Botanee Group and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $2.6B | XXX | $2.6B | XXX | XXX | XXX |
| EV (current) | $2.2B | XXX | $2.2B | XXX | XXX | XXX |
| EV/Revenue | 2.6x | XXX | 2.8x | XXX | XXX | XXX |
| EV/EBITDA | 17.5x | XXX | 19.4x | XXX | XXX | XXX |
| EV/EBIT | 22.6x | XXX | 27.4x | XXX | XXX | XXX |
| EV/Gross Profit | 3.6x | XXX | n/a | XXX | XXX | XXX |
| P/E | 32.1x | XXX | 37.2x | XXX | XXX | XXX |
| EV/FCF | 59.6x | XXX | 49.9x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialBotanee Group's last 12 month revenue growth is 10%
Botanee Group's revenue per employee in the last FY averaged n/a, while opex per employee averaged n/a for the same period.
Botanee Group's rule of 40 is 29% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Botanee Group's rule of X is 41% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Botanee Group and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 10% | XXX | 10% | XXX | XXX | XXX |
| EBITDA Margin | 15% | XXX | 14% | XXX | XXX | XXX |
| EBITDA Growth | 16% | XXX | -2% | XXX | XXX | XXX |
| Rule of 40 | 29% | XXX | 24% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 41% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | n/a | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 40% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | 5% | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 64% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Acme United | XXX | XXX | XXX | XXX | XXX | XXX |
| EZZ Life Science | XXX | XXX | XXX | XXX | XXX | XXX |
| Live Verdure | XXX | XXX | XXX | XXX | XXX | XXX |
| Lavipharm | XXX | XXX | XXX | XXX | XXX | XXX |
| Sarantis Group | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Botanee Group acquired XXX companies to date.
Last acquisition by Botanee Group was XXXXXXXX, XXXXX XXXXX XXXXXX . Botanee Group acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Botanee Group founded? | Botanee Group was founded in 2010. |
| Where is Botanee Group headquartered? | Botanee Group is headquartered in China. |
| Is Botanee Group publicy listed? | Yes, Botanee Group is a public company listed on SHE. |
| What is the stock symbol of Botanee Group? | Botanee Group trades under 300957 ticker. |
| When did Botanee Group go public? | Botanee Group went public in 2021. |
| Who are competitors of Botanee Group? | Similar companies to Botanee Group include e.g. Acme United, EZZ Life Science, Live Verdure, Lavipharm. |
| What is the current market cap of Botanee Group? | Botanee Group's current market cap is $2.6B |
| What is the current revenue of Botanee Group? | Botanee Group's last 12 months revenue is $828M. |
| What is the current revenue growth of Botanee Group? | Botanee Group revenue growth (NTM/LTM) is 10%. |
| What is the current EV/Revenue multiple of Botanee Group? | Current revenue multiple of Botanee Group is 2.6x. |
| Is Botanee Group profitable? | Yes, Botanee Group is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Botanee Group? | Botanee Group's last 12 months EBITDA is $125M. |
| What is Botanee Group's EBITDA margin? | Botanee Group's last 12 months EBITDA margin is 15%. |
| What is the current EV/EBITDA multiple of Botanee Group? | Current EBITDA multiple of Botanee Group is 17.5x. |
| What is the current FCF of Botanee Group? | Botanee Group's last 12 months FCF is $36.8M. |
| What is Botanee Group's FCF margin? | Botanee Group's last 12 months FCF margin is 4%. |
| What is the current EV/FCF multiple of Botanee Group? | Current FCF multiple of Botanee Group is 59.6x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
